These findings align with previous research, such as a study by Chang et al. [47], which showed that naringenin effectively reduced the migration and invasion of colon cancer cells by lowering the expression of MMPs and N-cadherin, both of which are critical for ECM and EMT regulation. The gene discussed is CDH2; the disease is malignant colon neoplasm.